1. [1] Chief Medical Officer, Chief Nursing Officer, Chief Pharmaceutical Officer (1999) Introduction of immunisation against group C meningococcal infection. Department of Health, London, PL/CMO/99/2, PL/CNO/99/4, PL/CPHO/99/1.
2. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants;Fairley;J. Infect. Dis.,1996
3. Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory;Richmond;J. Infect. Dis.,1999
4. Safety and Immunogenicity of a new Neisseria meningitidis Group C-tetanus toxoid conjugate vaccine in healthy adults;Richmond;Vaccine,1999
5. [5] Richmond, P.C., Borrow, R., Goldblatt, D., Findlow, J., Martin, S., Morris, R., Cartwright, K., Miller, E. Induction of immunological memory after a single dose of meningococcal C conjugate vaccine in UK toddlers. Submitted to Lancet.